# Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?

> **NCT03949946** · — · UNKNOWN · sponsor: **University of Aberdeen** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Magnetic resonance imaging (MRI)

## Key facts

- **NCT ID:** NCT03949946
- **Lead sponsor:** University of Aberdeen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-20
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949946, "Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03949946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*